PTX 2.50% 3.9¢ prescient therapeutics limited

Ann: PTX-200 AML Trial Progresses to Higher Dose, page-25

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,436 Posts.
    lightbulb Created with Sketch. 2059
    I agree davy its been a long time since any update. But have a look back previous announcements, and they do say both trials are on hold while they are redesigned.

    The AML trial at the moment is also redesigned since it started due to the interaction of PTX 200 and the combined chemo. I do wonder if this trial is helping with the redesign for Breast and Ovarian trials? All based on guess work with no real supporting evidence.

    Still with a market cap around $aud60 million, with PTX 200 AML and PTX 100 trials underway its an undervalued company. Add the Breast and ovarian as further trials in the future, not to mention Omnicar, the company has huge potential.

    As superT has stated PTX100 alone has huge potential.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
3.9¢
Change
-0.001(2.50%)
Mkt cap ! $31.40M
Open High Low Value Volume
4.1¢ 4.1¢ 3.9¢ $72.73K 1.802M

Buyers (Bids)

No. Vol. Price($)
5 436541 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 560576 1
View Market Depth
Last trade - 15.59pm 15/11/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.